Clinical Trials on Covid19, Vaccines in South Africa
Total 345 results
-
Sanofi Pasteur, a Sanofi CompanyActive, not recruitingCOVID-19United States, Colombia, Ghana, Honduras, India, Japan, Kenya, Mexico, Nepal, Nigeria, Sri Lanka, Uganda, Ukraine
-
BioNTech SEPfizerActive, not recruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
Children's Healthcare of AtlantaThe Hospital for Sick Children; Children's Hospital Medical Center, Cincinnati and other collaboratorsCompletedAcute Kidney Injury | COVIDUnited States, Canada, Spain, Israel, Japan, Serbia, United Kingdom
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); Pfizer; University of Copenhagen and other collaboratorsTerminatedCOVID-19United States, Denmark
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
Gilead SciencesTerminatedCOVID-19United States, Spain, Denmark, United Kingdom
-
AstraZenecaIqvia Pty LtdCompletedPhase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCOVID-19 | SARS-CoV-2United States, Chile, Peru
-
Regeneron PharmaceuticalsTerminatedCOVID-19United States, Mexico, Romania
-
AstraZenecaIqvia Pty LtdCompletedCOVID-19United States, Belgium, France, Spain, United Kingdom
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV2 InfectionUnited States, Puerto Rico
-
University of MinnesotaRecruitingCOVID-19United States, Denmark, Australia, Spain, Georgia, Korea, Republic of, Ukraine, Germany
-
NovavaxActive, not recruiting
-
AstraZenecaIqvia Pty LtdCompletedCOVID-19United States, United Kingdom
-
PfizerCompleted
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Korea, Republic of
-
MediMergent, LLCTerminatedSARS-CoV-2 InfectionUnited States
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
Alexion PharmaceuticalsTerminatedPneumonia, Viral | Acute Respiratory Distress Syndrome | Acute Lung Injury | COVID-19 Severe PneumoniaUnited States, Spain, United Kingdom, France, Japan
-
QuantumLeap Healthcare CollaborativeM.D. Anderson Cancer Center; University of Colorado, Denver; University of Pennsylvania and other collaboratorsRecruitingCOVID-19United States
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedSARS-CoV Infection | Coronavirus | Acute Respiratory InfectionUnited States
-
BioNTech SEPfizerCompletedCOVID-19 | Influenza, HumanUnited States
-
Regeneron PharmaceuticalsCompleted
-
BioNTech SEPfizerActive, not recruiting
-
PfizerCompletedCOVID-19United States, Taiwan, Italy, Canada, Greece
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaboratorsCompletedCOVID-19United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
National Institute of Allergy and Infectious Diseases...CompletedSARS-CoV-2 InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); AstraZeneca; University of... and other collaboratorsActive, not recruitingCOVID-19United States, Denmark, Greece, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaboratorsCompletedCOVID-19United States, Denmark, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline; University... and other collaboratorsCompletedCOVID-19United States, Denmark, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
Invivyd, Inc.TerminatedCOVID-19United States, Argentina, Czechia, Georgia, Germany, Moldova, Republic of, Poland, Romania, Ukraine
-
AstraZenecaCompletedCOVID-19United States, Spain, United Kingdom, Brazil, Germany, Ukraine, Japan, Italy, Poland, Russian Federation, Mexico, Czechia, Argentina, Hungary, Peru
-
Sean CollinsNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedCOVID-19 | Coronavirus Infection | SARS-CoV-2 InfectionUnited States
-
Eli Lilly and CompanyGlaxoSmithKline; Shanghai Junshi Bioscience Co., Ltd.; Vir Biotechnology, Inc.; AbCellera Biologics Inc...CompletedCOVID-19United States, Puerto Rico, Argentina
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
Ansun Biopharma, Inc.RecruitingCOVID-19 | Lower Respiratory Tract Infection | Immunocompromised | ParainfluenzaUnited States, Australia, China, Denmark, France, Hong Kong, Korea, Republic of, Taiwan
-
ModernaTX, Inc.Active, not recruitingCOVID-19United States, United Kingdom, Canada
-
ShionogiRecruitingSARS-CoV-2 InfectionJapan, United States
-
Regeneron PharmaceuticalsCompletedCOVID-19United States, Mexico, Romania, Brazil, Chile, Moldova, Republic of
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Autoimmunity Centers of ExcellenceCompletedSystemic Lupus Erythematosus (SLE) | Multiple Sclerosis (MS) | Rheumatoid Arthritis (RA) | Juvenile Dermatomyositis (JDM) | Juvenile Idiopathic Arthritis (JIA) | Pemphigus Vulgaris | Systemic Sclerosis (SSc) | Pediatric SLE | Pediatric-Onset Multiple Sclerosis (POMS)United States
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingHeart Failure | Pain | Pneumonia | Hypertension | Edema | Hemophilia | Insomnia | Pulmonary Arterial Hypertension | Coagulation Disorder | Asthma in Children | Down Syndrome | Attention Deficit Hyperactivity Disorder | Bronchopulmonary Dysplasia | Hypokalemia | Hyperphosphatemia | Primary Hyperaldosteronism | Adrenal Insufficiency and other conditionsUnited States, Canada